This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by DePasquale, M. J. Articles by Mangiapane, M. L. Search for Related Content PubMed PubMed Citation Articles by DePasquale, M. J. Articles by Mangiapane, M. L. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB LOSARTAN POTASSIUM

Hypertension, Vol 19, 668-671, Copyright © 1992 by American Heart Association

ARTICLES

Central DuP 753 does not lower blood pressure in spontaneously hypertensive rats

MJ DePasquale, AA Fossa, WF Holt and ML Mangiapane
Department of General Pharmacology, Pfizer Inc., Groton, Conn. 06340.

Oral administration of the angiotensin II receptor subtype 1 (AT1) antagonist DuP 753 causes long-lasting lowering of mean arterial pressure in spontaneously hypertensive rats. We examined whether the antihypertensive action of DuP 753 is a result of inhibition of brain angiotensin II. In normal spontaneously hypertensive rats, we found that intracerebroventricular DuP 753 (10 micrograms) blocked the pressor action of intracerebroventricular angiotensin II (100 ng); however, intracerebroventricular DuP 753 (10 micrograms) had no effect on the pressor response to 300 ng/kg angiotensin II administered intravenously (48 +/- 3 mm Hg in the presence of intracerebroventricular DuP 753 versus 49 +/- 4 mm Hg in its absence). In both normal and furosemide-treated spontaneously hypertensive rats (low Na+ diet plus furosemide), intracerebroventricular DuP 753 alone at 10 or 100 micrograms caused transient but significant pressor responses; however, no significant reduction in pressure (versus controls) was observed over the next 48 hours. In contrast to its central effects, we found that oral DuP 753 (10 or 30 mg/kg) in normal spontaneously hypertensive rats resulted in sustained mean arterial pressure decreases of up to -74 mm Hg. These data suggest that, although the pressor effect of brain angiotensin II is mediated by the AT1 receptor, blockade of these receptors does not lower blood pressure in spontaneously hypertensive rats. In the spontaneously hypertensive rat, DuP 753 depresses blood pressure by blockade of peripheral, not central, AT1 receptors.

This article has been cited by other articles:

				A. S. Budzikowski and F. H. H. Leenen ANG II in median preoptic nucleus and pressor responses to CSF sodium and high sodium intake in SHR Am J Physiol Heart Circ Physiol, September 1, 2001; 281(3): H1210 - H1216. [Abstract] [Full Text] [PDF]

				B. S. Huang, D. Ganten, and F. H. H. Leenen Responses to Central Na+ and Ouabain Are Attenuated in Transgenic Rats Deficient in Brain Angiotensinogen Hypertension, February 1, 2001; 37(2): 683 - 686. [Abstract] [Full Text] [PDF]

				J. T. FITZSIMONS Angiotensin, Thirst, and Sodium Appetite Physiol Rev, July 1, 1998; 78(3): 583 - 686. [Abstract] [Full Text] [PDF]

				P. Madeddu, P. P. Parpaglia, N. Glorioso, L. Chao, and J. Chao Antisense Inhibition of the Brain Kallikrein-Kinin System Hypertension, December 1, 1996; 28(6): 980 - 987. [Abstract] [Full Text]

				B. S. Huang and F. H.H. Leenen Brain "Ouabain" and Angiotensin II in Salt-Sensitive Hypertension in Spontaneously Hypertensive Rats Hypertension, December 1, 1996; 28(6): 1005 - 1012. [Abstract] [Full Text]

				D. Wielbo, C. Sernia, R. Gyurko, and M. I. Phillips Antisense Inhibition of Hypertension in the Spontaneously Hypertensive Rat Hypertension, March 1, 1995; 25(3): 314 - 319. [Abstract] [Full Text]

				M. A. Weber, R. L. Byyny, J. H. Pratt, E. P. Faison, D. B. Snavely, A. I. Goldberg, and E. B. Nelson Blood Pressure Effects of the Angiotensin II Receptor Blocker, Losartan Arch Intern Med, February 27, 1995; 155(4): 405 - 411. [Abstract] [PDF]